{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:06:43Z","timestamp":1792073203812,"version":"4.4.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Total neoadjuvant therapy (TNT) is a novel approach for locally advanced rectal cancer (LARC), which attempts to deliver both systemic chemotherapy and neoadjuvant chemoradiotherapy prior to surgery. However, its efficacy and safety remain controversial in randomized controlled trials (RCTs). We conducted this meta-analysis to assess such concerns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Head-to-head phase II\/III RCTs were searched in Embase, PubMed, Web of Science, and the Cochrane Library, as well as other sources. The primary endpoint was pathologic complete response (pCR). Secondary endpoints were disease-free survival (DFS), overall survival (OS), local recurrence-free survival, distant metastasis-free survival, and the R0 resection rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eight phase II\/III RCTs involving 2,196 patients with LARC were assessed. The primary analysis demonstrated a statistically significant improvement in the pCR rate for TNT treatment (odds ratio, 1.77; 95% confidence interval [CI], 1.28\u20132.45; p\u00a0=\u00a0.0005). TNT treatment also showed improvements in DFS and OS outcomes compared with standard chemoradiotherapy (hazard ratio [HR], 0.83; 95% CI, 0.72\u20130.96; p\u00a0=\u00a0.03 and HR, 0.88; 95% CI, 0.74\u20131.05; p\u00a0=\u00a0.15). In addition, TNT treatment showed significant efficacy in reducing the risk of distant metastasis (HR, 0.81; 95% CI, 0.68\u20130.95; p\u00a0=\u00a0.012).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The overall pCR rate may be improved with TNT compared with standard treatment. The TNT strategy may also improve DFS and OS and reduce the risk of distant metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Practice<\/jats:title>\n                    <jats:p>Locally advanced rectal cancer (LARC) is a relatively common disease, with a poor prognosis because of its high metastatic potential. The role of total neoadjuvant therapy (TNT) has always been controversial. This meta-analysis found that TNT in LARC is associated with a significant improvement in overall pathologic complete response rate, disease-free survival, overall survival, and distant metastasis-free survival compared with standard treatment. TNT is a promising strategy for LARC, especially for patients who have little desire for surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/onco.13824","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:11:20Z","timestamp":1620958280000},"page":"e1555-e1566","source":"Crossref","is-referenced-by-count":219,"title":["Total Neoadjuvant Therapy (\n                    <scp>TNT<\/scp>\n                    ) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and\n                    <scp>Meta-Analysis<\/scp>"],"prefix":"10.1093","volume":"26","author":[{"given":"Shuang","family":"Liu","sequence":"first","affiliation":[{"name":"Departments of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China"},{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China"},{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Section II, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanfei","family":"Yang","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China"},{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China"},{"name":"Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhong","family":"Gao","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China"},{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China"},{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9922-640X","authenticated-orcid":false,"given":"Weiwei","family":"Xiao","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China"},{"name":"Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"2022012102412999300_onco13824-bib-0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3322\/caac.21395","article-title":"Colorectal cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2022012102412999300_onco13824-bib-0002","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"key":"2022012102412999300_onco13824-bib-0003","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cncr.30600","article-title":"Total neoadjuvant therapy for rectal cancer: An emerging option","volume":"123","author":"Ludmir","year":"2017","journal-title":"Cancer"},{"key":"2022012102412999300_onco13824-bib-0004","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/DCR.0000000000000558","article-title":"Pathologic complete response in rectal cancer: Can we detect it? Lessons learned from a proposed randomized trial of watch-and-wait treatment of rectal cancer","volume":"59","author":"Nahas","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"2022012102412999300_onco13824-bib-0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial","volume":"13","author":"Rodel","year":"2012","journal-title":"Lancet Oncol"},{"key":"2022012102412999300_onco13824-bib-0006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11605-012-2073-5","article-title":"Hospital readmission for fluid and electrolyte abnormalities following ileostomy construction: Preventable or unpredictable?","volume":"17","author":"Hayden","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"2022012102412999300_onco13824-bib-0007","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.bjc.6602960","article-title":"Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: Should we be more cautious?","volume":"94","author":"Glynne-Jones","year":"2006","journal-title":"Br J Cancer"},{"key":"2022012102412999300_onco13824-bib-0008","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0000000000003471","article-title":"Total neoadjuvant therapy in rectal cancer: A systematic review and meta-analysis of treatment outcomes","volume":"271","author":"Petrelli","year":"2020","journal-title":"Ann Surg"},{"key":"2022012102412999300_onco13824-bib-0009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jclinpath-2018-205595","article-title":"Neoadjuvant chemoradiation in locally advanced rectal cancer: The surgeon's perspective","volume":"72","author":"Azin","year":"2019","journal-title":"J Clin Pathol"},{"key":"2022012102412999300_onco13824-bib-0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.canrad.2018.01.004","article-title":"Total neoadjuvant therapy for rectal cancer","volume":"22","author":"Goodman","year":"2018","journal-title":"Cancer Radiother"},{"key":"2022012102412999300_onco13824-bib-0011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ags3.12349","article-title":"Challenges and shifting treatment strategies in the surgical treatment of locally advanced rectal cancer","volume":"4","author":"Kim","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"key":"2022012102412999300_onco13824-bib-0012","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clon.2015.11.003","article-title":"Neoadjuvant treatment strategies for locally advanced rectal cancer","volume":"28","author":"Gollins","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2022012102412999300_onco13824-bib-0013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(09)70381-X","article-title":"Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: A phase 2 trial","volume":"11","author":"Chua","year":"2010","journal-title":"Lancet Oncol"},{"key":"2022012102412999300_onco13824-bib-0014","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ijrobp.2014.07.021","article-title":"Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: A prospective phase 2 trial","volume":"90","author":"Gao","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022012102412999300_onco13824-bib-0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total neoadjuvant therapy for locally advanced rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"key":"2022012102412999300_onco13824-bib-0016","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/annonc\/mdr431","article-title":"High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH)","volume":"22","author":"Kenz","year":"2011","journal-title":"Ann Oncol"},{"key":"2022012102412999300_onco13824-bib-0017","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/annonc\/mdr473","article-title":"Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: A randomized multicentric phase II study","volume":"23","author":"Mar\u00e9chal","year":"2012","journal-title":"Ann Oncol"},{"key":"2022012102412999300_onco13824-bib-0018","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/annonc\/mdv223","article-title":"Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: Long-term results of the Spanish GCR-3 phase II randomized trial\u2020","volume":"26","author":"Fernandez-Martos","year":"2015","journal-title":"Ann Oncol"},{"issue":"suppl 9","key":"2022012102412999300_onco13824-bib-0019","first-page":"ix70","article-title":"Phase III study of short-term radiotherapy followed by neoadjuvant chemotherapy versus preoperative long-term chemoradiotherapy in locally advanced rectal cancer","volume":"26","author":"Tang","year":"2015","journal-title":"Ann Oncol"},{"key":"2022012102412999300_onco13824-bib-0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5 \u00d75 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: Results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann Oncol"},{"key":"2022012102412999300_onco13824-bib-0021","doi-asserted-by":"crossref","first-page":"e1500a","DOI":"10.1200\/JCO.2016.34.15_suppl.e15000","article-title":"The initial results for a phase III study of short-term radiotherapy plus chemotherapy vs long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR trial)","volume":"34","author":"Jin","year":"2016","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"2022012102412999300_onco13824-bib-0022","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.ijrobp.2016.06.266","article-title":"The initial results for a phase 3 study of short-term versus long-term chemoradiation therapy in locally advanced rectal cancer (STELLAR trial)","volume":"96","author":"Tang","year":"2016","journal-title":"Int J Radiat Oncol"},{"issue":"suppl","key":"2022012102412999300_onco13824-bib-0023","article-title":"The updated results for the phase 3 study of 5\u00d75 Gy followed by chemotherapy in locally advanced rectal cancer (stellar trial)","volume":"99","author":"Jin","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022012102412999300_onco13824-bib-0024","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/codi.13724","article-title":"Prospective randomized trial of neoadjuvant chemotherapy during the \u2018wait period\u2019 following preoperative chemoradiotherapy for rectal cancer: Results of the WAIT trial","volume":"19","author":"Moore","year":"2017","journal-title":"Colorectal Dis"},{"issue":"suppl 8","key":"2022012102412999300_onco13824-bib-0025","doi-asserted-by":"crossref","first-page":"viii167","DOI":"10.1093\/annonc\/mdy281.043","article-title":"Short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): A planned interim analysis","volume":"29","author":"Jin","year":"2018","journal-title":"Ann Oncol"},{"key":"2022012102412999300_onco13824-bib-0026","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ijrobp.2018.04.013","article-title":"A randomized phase 2 trial of consolidation chemotherapy after preoperative chemoradiation therapy versus chemoradiation therapy alone for locally advanced rectal cancer: KCSG CO 14-03","volume":"101","author":"Kim","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022012102412999300_onco13824-bib-0027","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation versus 5 \u00d7\u20095 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: Long-term results of the randomized Polish II study","volume":"30","author":"Cise\u0142","year":"2019","journal-title":"Ann Oncol"},{"key":"2022012102412999300_onco13824-bib-0028","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","article-title":"Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo C\u00e1ncer de Recto 3 study","volume":"28","author":"Fern\u00e1ndez-Martos","year":"2010","journal-title":"J Clin Oncol"},{"key":"2022012102412999300_onco13824-bib-0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2020.03.011","article-title":"Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer \u2013 Results of the international randomized RAPIDO-trial","volume":"147","author":"Valk","year":"2020","journal-title":"Radiother Oncol"},{"issue":"suppl","key":"2022012102412999300_onco13824-bib-0030","doi-asserted-by":"crossref","first-page":"4007a","DOI":"10.1200\/JCO.2020.38.15_suppl.4007","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial","volume":"38","author":"Conroy","year":"2020","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"2022012102412999300_onco13824-bib-0031","doi-asserted-by":"crossref","first-page":"4006a","DOI":"10.1200\/JCO.2020.38.15_suppl.4006","article-title":"Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial","volume":"38","author":"Hospers","year":"2020","journal-title":"J Clin Oncol"},{"key":"2022012102412999300_onco13824-bib-0032","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"2022012102412999300_onco13824-bib-0033","doi-asserted-by":"crossref","first-page":"4008a","DOI":"10.1200\/JCO.2020.38.15_suppl.4008","article-title":"Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial","volume":"38","author":"Garcia-Aguilar","year":"2020","journal-title":"J Clin Oncol"},{"key":"2022012102412999300_onco13824-bib-0034","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: A multicentre, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"key":"2022012102412999300_onco13824-bib-0035","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/DCR.0000000000001207","article-title":"Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: Final results of a multicenter phase II trial","volume":"61","author":"Marco","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"suppl 2","key":"2022012102412999300_onco13824-bib-0036","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000342038","article-title":"Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: How and who should be treated?","volume":"30","author":"R\u00f6del","year":"2012","journal-title":"Dig Dis"},{"key":"2022012102412999300_onco13824-bib-0037","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/annonc\/mdt124","article-title":"Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer","volume":"24","author":"Van Dijk","year":"2013","journal-title":"Ann Oncol"},{"key":"2022012102412999300_onco13824-bib-0038","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijrobp.2017.05.048","article-title":"Improved metastasis- and disease-free survival with preoperative sequential short-course radiation therapy and FOLFOX chemotherapy for rectal cancer compared with neoadjuvant long-course chemoradiotherapy: Results of a matched pair analysis","volume":"99","author":"Markovina","year":"2017","journal-title":"Int J Radiat Onco Biol Phys"},{"key":"2022012102412999300_onco13824-bib-0039","doi-asserted-by":"crossref","first-page":"101908","DOI":"10.1016\/j.ctrv.2019.101908","article-title":"Should we favour the use of 5 \u00d7 5 preoperative radiation in rectal cancer","volume":"81","author":"Kane","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"2022012102412999300_onco13824-bib-0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"2022012102412999300_onco13824-bib-0041","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"2022012102412999300_onco13824-bib-0042","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1186\/s12885-016-2959-9","article-title":"Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: Results of a randomized controlled trial","volume":"16","author":"Latkauskas","year":"2016","journal-title":"BMC Cancer"},{"key":"2022012102412999300_onco13824-bib-0043","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.suronc.2014.10.003","article-title":"Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: A systematic review and meta-analysis","volume":"23","author":"Zhou","year":"2014","journal-title":"Surg Oncol"},{"key":"2022012102412999300_onco13824-bib-0044","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clcc.2018.07.014","article-title":"Short-course radiotherapy in neoadjuvant treatment for rectal cancer: A systematic review and meta-analysis","volume":"17","author":"Ma","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"2022012102412999300_onco13824-bib-0045","article-title":"Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data","volume":"13","author":"Wang","year":"2018","journal-title":"PloS One"},{"key":"2022012102412999300_onco13824-bib-0046","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","article-title":"Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial","volume":"17","author":"Francois","year":"1999","journal-title":"J Clin Oncol"},{"key":"2022012102412999300_onco13824-bib-0047","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.2016.67.6049","article-title":"Effect of interval (7 or 11\u2009weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: A multicenter, randomized, controlled trial (GRECCAR-6)","volume":"34","author":"Lefevre","year":"2016","journal-title":"J Clin Oncol"},{"key":"2022012102412999300_onco13824-bib-0048","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11605-010-1197-8","article-title":"Neoadjuvant therapy for rectal cancer: The impact of longer interval between chemoradiation and surgery","volume":"15","author":"Campos-Lobato","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"2022012102412999300_onco13824-bib-0049","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1245\/s10434-012-2327-1","article-title":"Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome","volume":"19","author":"Wolthuis","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2022012102412999300_onco13824-bib-0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jamcollsurg.2015.12.017","article-title":"Optimal timing to surgery after neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"222","author":"Sun","year":"2016","journal-title":"J Am Coll Surg"},{"key":"2022012102412999300_onco13824-bib-0051","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.3748\/wjg.v26.i31.4624","article-title":"Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients","volume":"26","author":"Mei","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2022012102412999300_onco13824-bib-0052","volume-title":"TNT Versus Conventional CRT to Increase the Sphincter Preservation Rate for Distal LARC (TESS)","author":"Xiao","year":"2019"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/onco.13824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/onco.13824","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/9\/e1555\/42247118\/oncolo_26_9_e1555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/9\/e1555\/42247118\/oncolo_26_9_e1555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T21:42:09Z","timestamp":1642714929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/26\/9\/e1555\/6512123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,6,7]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/onco.13824","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,6,7]]}}}